CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo
2018 ◽
Vol 113
◽
pp. 813-820
◽
Keyword(s):
2015 ◽
Vol 9
(5)
◽
pp. 1791-1796
◽